Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
In Vitro Drug Response: Viability Versus Cell Death
2026-08-15
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell killing are related but non-equivalent dimensions of anticancer drug response. Its central practical implication is that cancer research workflows should separate proliferative arrest from death and consider their relative timing rather than treating one viability value as a complete pharmacologic profile.
-
Demethyleneberberine: Applied Research Workflows
2026-08-14
Demethyleneberberine (DMB) is a versatile research compound for connecting inflammatory, mitochondrial, neurodegenerative, and cancer phenotypes to measurable signaling events. This workflow-focused guide covers formulation, model selection, pathway assays, dose translation, and troubleshooting for more reproducible results.
-
Direct Mouse Genotyping Kit Plus for Atherosclerosis
2026-08-14
The Direct Mouse Genotyping Kit Plus turns small mouse tissue samples into PCR-ready lysates, helping researchers verify alleles, screen colonies, and organize cardiovascular studies with fewer purification steps. Its 2X high-fidelity PCR master mix with dye reagents also simplifies gel-based interpretation when genotyping EP4- or ApoE-related mouse models.
-
Mubritinib (TAK 165): An OXPHOS Assay Guide
2026-08-13
Mubritinib, also known as TAK 165, is more informative as a mitochondrial complex I probe than as a conventional HER2 inhibitor. This guide translates AML and PEL evidence into practical assay-design decisions, including metabolic readouts, controls, dosing, and interpretation limits.
-
Pexidartinib (PLX3397) for TAM Assays
2026-08-13
Pexidartinib (PLX3397) provides a practical CSF1R perturbation tool for macrophage depletion, signaling studies, and tumor co-culture models. Paired with SPP1-focused phenotypic assays, it helps distinguish CSF1R-dependent macrophage biology from direct SPP1 modulation in cancer research.
-
Rotigotine in Parkinson’s Disease Research Workflows
2026-08-12
Build route-aware Rotigotine experiments that connect dopamine receptor pharmacology with neuroprotection and PD-associated bladder dysfunction. This practical guide covers cell assays, 6-OHDA cystometry, formulation controls, and troubleshooting for more interpretable translational data.
-
Ceftazidime for Reproducible Cell Assays
2026-08-12
Learn how Ceftazidime (SKU B3539) can help investigators separate antimicrobial effects from mammalian-cell viability signals in infection, contamination, and cytotoxicity workflows. This scenario-based guide integrates formulation details, assay controls, storage guidance, and recent carbapenemase-transmission evidence.
-
EZ Cap EGFP mRNA 5-moUTP Workflow Guide
2026-08-11
Build reproducible reporter, delivery, and translation workflows with a capped, modified enhanced green fluorescent protein mRNA. This guide connects practical handling and troubleshooting with the reference study’s delivery-vector framework, helping researchers distinguish RNA performance from formulation performance.
-
ML133 HCl: Kir2.1 Assay Workflow Guide
2026-08-11
Build cleaner Kir2.1 experiments with ML133 HCl, a selective potassium channel inhibitor suited to channel physiology and pulmonary vascular remodeling assays. This guide translates published PASMC workflows into practical dosing, controls, readouts, and troubleshooting strategies.
-
Pexidartinib: TAM State, Not Just Depletion
2026-08-10
Pexidartinib (PLX3397) offers a powerful way to interrogate CSF1R biology, but its most informative use may be distinguishing macrophage depletion from phenotype remodeling. This guide connects CSF1R-mediated signaling inhibition with the SPP1-focused tumor-associated macrophage research and translates that distinction into practical assay design.
-
RG108 DNA Methyltransferase Inhibitor Workflow
2026-08-09
RG108 enables reversible DNMT inhibition for controlled DNA demethylation, tumor suppressor gene reactivation, and cell-based epigenetic studies. This practical guide connects formulation, dosing, orthogonal readouts, and troubleshooting with assay-design lessons from recent antiviral research without overstating cross-domain evidence.
-
LMO2–LDB1 Signaling in Acute Myeloid Leukemia
2026-08-08
A 2023 study identifies an LMO2/LDB1 protein complex as a functional regulator of acute myeloid leukemia cell survival and proliferation. By combining perturbation experiments, immunoprecipitation–mass spectrometry, RNA-seq, ChIP-seq, and rescue analysis, the authors connect LDB1-dependent transcriptional regulation with apoptosis-related gene control and AML maintenance.
-
ATRX Loss Sensitizes High-Grade Glioma to RTK Inhibitors
2026-08-07
The reference study shows that loss of the chromatin remodeler ATRX creates a selective vulnerability to several multi-targeted receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its combination data with temozolomide support ATRX status as a useful variable for interpreting targeted-therapy studies, although the findings remain primarily cellular and require further translational validation.
-
S-Adenosylhomocysteine: Mechanisms, Inhibition, and Research
2026-08-07
S-Adenosylhomocysteine (SAH) is a central metabolic intermediate and methyltransferase inhibitor. It regulates the methylation cycle and the SAM/SAH ratio, impacting cellular growth and epigenetic modulation. APExBIO’s SAH (SKU B6123) offers high purity and robust solubility for advanced biochemical and neurobiological research.
-
Cy3 TSA Fluorescence System Kit: Enabling Endothelial Pathwa
2026-08-06
Explore how the Cy3 TSA Fluorescence System Kit transforms signal amplification in immunohistochemistry and fluorescence microscopy detection, uniquely empowering research into endothelial signaling mechanisms and low-abundance biomolecule visualization. Discover protocol insights, comparative analysis, and advanced applications grounded in the latest cardiac inflammation research.